Authors:
Gercel-Taylor, C
Ackermann, MA
Taylor, DD
Citation: C. Gercel-taylor et al., Evaluation of cell proliferation and cell death based assays in chemosensitivity testing, ANTICANC R, 21(4A), 2001, pp. 2761-2768
Authors:
Bosscher, JR
Gercel-Taylor, C
Watkins, CS
Taylor, DD
Citation: Jr. Bosscher et al., Epitope recognition by anti-cathepsin D autoantibodies in endometrial cancer patients, GYNECOL ONC, 81(2), 2001, pp. 138-143
Citation: C. Gercel-taylor et al., Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer, GYNECOL ONC, 81(1), 2001, pp. 71-76
Authors:
Taylor, DD
Bender, DP
Gercel-Taylor, C
Stanson, J
Whiteside, T
Citation: Dd. Taylor et al., Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients, BR J CANC, 84(12), 2001, pp. 1624-1629
Authors:
Wilbur, DC
Prey, MU
Miller, WM
Pawlick, GF
Colgan, TJ
Taylor, DD
Citation: Dc. Wilbur et al., AutoPap system detection of infections and benign cellular changes: Results from primary screener clinical trials, DIAGN CYTOP, 21(5), 1999, pp. 355-358
Authors:
Bazzett, LB
Watkins, CS
Gercel-Taylor, C
Taylor, DD
Citation: Lb. Bazzett et al., Modulation of proliferation and chemosensitivity by procathepsin D and itspeptides in ovarian cancer, GYNECOL ONC, 74(2), 1999, pp. 181-187
Authors:
Wilbur, DC
Prey, MU
Miller, WM
Pawlick, GF
Colgan, TJ
Taylor, DD
Citation: Dc. Wilbur et al., Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap System - Results of a primary screening clinical trial, CANC CYTOP, 87(6), 1999, pp. 354-358